GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Themis Biosyn Ltd (BOM:506879) » Definitions » Interest Expense

Gujarat Themis Biosyn (BOM:506879) Interest Expense : ₹-3 Mil (TTM As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Gujarat Themis Biosyn Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Gujarat Themis Biosyn's interest expense for the three months ended in Dec. 2024 was ₹ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Gujarat Themis Biosyn's Operating Income for the three months ended in Dec. 2024 was ₹ 173 Mil. Gujarat Themis Biosyn's Interest Expense for the three months ended in Dec. 2024 was ₹ -1 Mil. Gujarat Themis Biosyn's Interest Coverage for the quarter that ended in Dec. 2024 was 119.75. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Gujarat Themis Biosyn Interest Expense Historical Data

The historical data trend for Gujarat Themis Biosyn's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Themis Biosyn Interest Expense Chart

Gujarat Themis Biosyn Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.57 -7.90 -7.33 -0.95 -1.43

Gujarat Themis Biosyn Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.79 0.12 -0.66 -0.83 -1.45

Gujarat Themis Biosyn Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gujarat Themis Biosyn  (BOM:506879) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gujarat Themis Biosyn's Interest Expense for the three months ended in Dec. 2024 was ₹-1 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹173 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Gujarat Themis Biosyn's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*173.032/-1.445
=119.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Gujarat Themis Biosyn Ltd has enough cash to cover all of its debt. Its financial situation is stable.


Gujarat Themis Biosyn Business Description

Traded in Other Exchanges
Address
S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.

Gujarat Themis Biosyn Headlines

No Headlines